Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expert clinical management of autoimmune hepatitis in the real world.
Liberal R, de Boer YS, Andrade RJ, Bouma G, Dalekos GN, Floreani A, Gleeson D, Hirschfield GM, Invernizzi P, Lenzi M, Lohse AW, Macedo G, Milkiewicz P, Terziroli B, van Hoek B, Vierling JM, Heneghan MA; International Autoimmune Hepatitis Group (IAIHG). Liberal R, et al. Among authors: milkiewicz p. Aliment Pharmacol Ther. 2017 Mar;45(5):723-732. doi: 10.1111/apt.13907. Epub 2016 Dec 22. Aliment Pharmacol Ther. 2017. PMID: 28004405 Free article.
Loss of mucosal tolerance to glycoprotein 2 isoform 1 is a potential novel diagnostic biomarker for cholangiocarcinoma.
Xia CS, Krawczyk M, Di C, Krupa Ł, Kruk B, Krawczyk P, Milkiewicz P, Bao H, He X, Liu D, Fan C, Nasser A, Lopens S, Weiss FU, Frost F, Schierack P, Roggenbuck D, Liu Y. Xia CS, et al. Among authors: milkiewicz p. Dig Liver Dis. 2024 Jun 8:S1590-8658(24)00785-0. doi: 10.1016/j.dld.2024.05.027. Online ahead of print. Dig Liver Dis. 2024. PMID: 38853092
Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis.
Salzmann RJS, Krötz C, Mocan T, Mocan LP, Grapa C, Rottmann S, Reichelt R, Keller CM, Langhans B, Schünemann F, Pohl A, Böhler T, Bersiner K, Krawczyk M, Milkiewicz P, Sparchez Z, Lammert F, Gehlert S, Gonzalez-Carmona MA, Willms A, Strassburg CP, Kornek MT, Dold L, Lukacs-Kornek V. Salzmann RJS, et al. Among authors: milkiewicz p. Hepatol Commun. 2024 Feb 14;8(3):e0380. doi: 10.1097/HC9.0000000000000380. eCollection 2024 Mar 1. Hepatol Commun. 2024. PMID: 38358371 Free PMC article.
Oxidative stress in metabolic dysfunction-associated steatotic liver disease (MASLD): How does the animal model resemble human disease?
Jakubek P, Kalinowski P, Karkucinska-Wieckowska A, Kaikini A, Simões ICM, Potes Y, Kruk B, Grajkowska W, Pinton P, Milkiewicz P, Grąt M, Pronicki M, Lebiedzinska-Arciszewska M, Krawczyk M, Wieckowski MR. Jakubek P, et al. Among authors: milkiewicz p. FASEB J. 2024 Feb 15;38(3):e23466. doi: 10.1096/fj.202302447R. FASEB J. 2024. PMID: 38318780
Maternal liver-related symptoms during pregnancy in primary sclerosing cholangitis.
Nayagam JS, Weismüller TJ, Milkiewicz P, Wronka KM, Bik E, Schramm C, Fuessel K, Zhou T, Chang J, Färkkilä M, Carlsson Y, Lundman A, Cazzagon N, Corrà G, Rigopoulou E, Dalekos GN, Båve AL, Bergquist A, Ben Belkacem K, Marzioni M, Mancinelli M, Verhelst X, Marschall HU, Heneghan MA, Joshi D; International PSC Study Group (IPSCSG). Nayagam JS, et al. Among authors: milkiewicz p. JHEP Rep. 2023 Oct 31;6(1):100951. doi: 10.1016/j.jhepr.2023.100951. eCollection 2024 Jan. JHEP Rep. 2023. PMID: 38089547 Free PMC article.
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.
Colapietro F, Maisonneuve P, Lytvyak E, Beuers U, Verdonk RC, van der Meer AJ, van Hoek B, Kuiken SD, Brouwer JT, Muratori P, Aghemo A, Carella F, van den Berg AP, Zachou K, Dalekos GN, Di Zeo-Sánchez DE, Robles M, Andrade RJ, Montano-Loza AJ, van den Brand FF, Slooter CD, Macedo G, Liberal R, de Boer YS, Lleo A; Dutch AIH Study Group; International Autoimmune Hepatitis Group. Colapietro F, et al. J Hepatol. 2024 Jan;80(1):53-61. doi: 10.1016/j.jhep.2023.09.010. Epub 2023 Oct 5. J Hepatol. 2024. PMID: 37802188
HLA-DPA1*02:01~B1*01:01 is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cells.
Zecher BF, Ellinghaus D, Schloer S, Niehrs A, Padoan B, Baumdick ME, Yuki Y, Martin MP, Glow D, Schröder-Schwarz J, Niersch J, Brias S, Müller LM, Habermann R, Kretschmer P, Früh T, Dänekas J, Wehmeyer MH, Poch T, Sebode M; International PSC Study Group (IPSCSG); Ellinghaus E, Degenhardt F, Körner C, Hoelzemer A, Fehse B, Oldhafer KJ, Schumacher U, Sauter G, Carrington M, Franke A, Bunders MJ, Schramm C, Altfeld M. Zecher BF, et al. Gut. 2024 Jan 5;73(2):325-337. doi: 10.1136/gutjnl-2023-329524. Gut. 2024. PMID: 37788895 Free PMC article.
238 results